HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Critique of Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation trial.

AuthorsRoland Veltkamp, Shyam Prabhakaran
JournalStroke (Stroke) Vol. 45 Issue 7 Pg. 2151-3 (Jul 2014) ISSN: 1524-4628 [Electronic] United States
PMID24916907 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Factor Xa Inhibitors
  • Pyridines
  • Thiazoles
  • Warfarin
  • edoxaban
Topics
  • Adult
  • Atrial Fibrillation (complications)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Factor Xa Inhibitors
  • Humans
  • Pyridines (administration & dosage, adverse effects, pharmacology)
  • Randomized Controlled Trials as Topic (standards)
  • Stroke (etiology, metabolism, prevention & control)
  • Thiazoles (administration & dosage, adverse effects, pharmacology)
  • Treatment Outcome
  • Warfarin (administration & dosage, adverse effects, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: